Invesco Ltd. - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 67 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$15,712
-7.8%
17,518
+21.2%
0.00%
Q4 2022$17,049
-85.9%
14,448
-10.1%
0.00%
Q3 2022$121,000
+36.0%
16,069
+14.3%
0.00%
Q2 2022$89,000
+17.1%
14,061
+22.7%
0.00%
Q3 2021$76,000
-11.6%
11,461
+13.4%
0.00%
Q2 2021$86,00010,1040.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,787,091$14,118,0003.56%
INTERWEST VENTURE MANAGEMENT CO 1,599,592$12,637,0002.99%
SPHERA FUNDS MANAGEMENT LTD. 385,301$3,044,0000.52%
Boxer Capital, LLC 138,331$1,093,0000.26%
DAFNA Capital Management LLC 35,977$284,0000.20%
SABBY MANAGEMENT, LLC 223,100$1,762,0000.12%
Hikari Power Ltd 60,992$482,0000.06%
Perceptive Advisors 157,679$1,245,0000.06%
Lombard Odier Asset Management (USA) Corp 90,000$711,0000.06%
TFS CAPITAL LLC 12,128$96,0000.04%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders